Project 3 HMS - VA sub

项目 3 HMS - VA 子

基本信息

项目摘要

ABSTRACT Obstructive sleep apnea (OSA) is characterized by frequent arousals from sleep due to closure of the upper airway, producing hypercapnia (increased carbon dioxide levels) and hypoxia (decreased oxygen levels). The consequences of OSA include excessive daytime sleepiness, cognitive deficits, as well as respiratory, metabolic, and cardiovascular disorders. Despite its importance in OSA-induced arousals and sleep fragmentation, very little is known about the neural mechanisms that mediate arousals during OSA. Recent work indicates that the brainstem glutamatergic neurons of the parabrachial complex (PB), which receive visceral and respiratory input, are important for hypercapnic arousal. We hypothesize that the PB projections to the basal forebrain (BF), a region containing cortically projecting & wakefulness promoting neurons, mediate the cortical arousal response to the hypercapnia. Sleep apnea will be modeled in mice by exposure to hypercapnia during sleep, termed repetitive carbon dioxide-mediated arousals (RCA). Optogenetic techniques will be used to investigate the roles of three neurotransmitter-defined subpopulations of cortically-projecting BF neurons in apnea-induced arousals: GABAergic parvalbumin positive (PV), cholinergic, and glutamatergic neurons. For each identified BF neurotransmitter phenotype we will address the criteria of: 1) sufficiency for arousal by optogenetic excitation using Channelrhodopsin 2 (ChR2); 2) necessity for arousal by optogenetic inhibition of RCA using Archaerhodopsin (ArchT); and 3) relevance of our optogenetic findings to natural physiological conditions by recording the electrical activity of RCA -related BF neurons whose neurotransmitter phenotype has been defined by short latency excitation by ChR2. Each neuronal BF population will be evaluated as mice are exposed to RCA or acoustic stimuli; we predict both stimuli will arouse, as our data point to the BF as a final common pathway leading to cortical arousal from both visceral and external sensory stimuli. Our preliminary data point to PV GABergic neurons as the most important for RCA and acoustic arousals: 1) ChR2 excitation of BF PV neurons causes arousal and EEG activation including high frequency oscillations; 2) PV ArchT inhibition markedly prolongs the latency to RCA arousal; and 3) PV unit recordings show activation in concert with cortical activation. In contrast, ChR2 stimulation of BF cholinergic neurons shows more modulatory, less powerful and less immediate effects on cortical activation than PV neurons. We predict that glutamatergic BF neurons will play a role in promoting arousal, but not high frequency oscillations. If successful, these experiments would suggest that blocking BF activation, especially that from GABAergic PV neurons, would increase the cortical arousal threshold, and thus would treat the sleep fragmentation evident in apnea and responsible for many of the symptoms of OSA. Improved understanding of the neural mechanisms controlling cortical arousals in OSA will guide therapeutic treatment aiming to decrease cortical arousals while maintaining airway patency.
摘要 阻塞性睡眠呼吸暂停(OSA)的特征是由于睡眠关闭而频繁从睡眠中唤醒 上呼吸道,产生高碳酸血症(二氧化碳水平增加)和低氧(氧气减少 级别)。阻塞性睡眠呼吸暂停的后果包括白天过度嗜睡、认知缺陷以及 呼吸系统、代谢和心血管疾病。尽管它在阻塞性睡眠呼吸暂停综合征诱导的觉醒和 睡眠碎片,人们对阻塞性睡眠呼吸暂停时调节觉醒的神经机制知之甚少。 最近的研究表明,臂旁复合体(PB)的脑干谷氨酸能神经元 接受内脏和呼吸输入,对于高碳酸血症的唤醒很重要。我们假设PB 投射到基底前脑(BF),这是一个包含皮质投射和觉醒促进的区域 神经元,调节皮层对高碳酸血症的唤醒反应。睡眠呼吸暂停将在小鼠身上建立模型 在睡眠期间暴露于高碳酸血症,称为重复性二氧化碳介导的觉醒(RCA)。 光遗传学技术将被用来研究神经递质定义的三个亚群的作用 在呼吸暂停诱发觉醒中皮质投射的BF神经元:GABA能小白蛋白阳性(PV), 胆碱能和谷氨酸能神经元。对于每一种已识别的BF神经递质表型,我们将解决 标准:1)利用通道视紫红质2(ChR2)的光遗传兴奋的充分性;2)必要性 通过使用古紫红质(ARCHT)光遗传抑制RCA的觉醒;以及3)我们的 记录RCA相关BF电活动对自然生理条件的光遗传学研究 神经递质表型由ChR2的短潜伏期兴奋定义。每个人 当小鼠暴露在RCA或声刺激下时,将对神经元BF种群进行评估;我们预测两者都有 刺激将被唤醒,因为我们的数据表明,BF是最终的共同途径,从两者通向皮质唤醒 内脏和外部感官刺激。我们的初步数据表明,最常见的是PVGABe能神经元 对RCA和听觉觉醒的重要作用:1)BF PV神经元ChR2的兴奋引起觉醒和脑电 激活包括高频振荡;2)抑制PV ARCHT可显著延长RCA的潜伏期 觉醒;以及3)光伏单位记录显示激活与皮质激活一致。相比之下,ChR2 刺激BF胆碱能神经元表现出更强的调节性,更弱的威力和更少的即时效应 皮质激活程度高于PV神经元。我们预测谷氨酸能BF神经元将发挥促进作用 唤醒,但不是高频振荡。如果成功,这些实验将表明阻止BF 激活,特别是GABA能PV神经元的激活,会提高皮质觉醒阈值,从而 将治疗呼吸暂停症中明显的睡眠碎片,并对OSA的许多症状负责。 提高对阻塞性睡眠呼吸暂停患者皮质觉醒控制神经机制的理解将指导治疗 旨在减少皮质唤醒同时保持呼吸道通畅的治疗。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Robert W McCarley其他文献

P300 as An Index of Transition to Psychosis and of Remission: Data from A Clinical High Risk for Psychosis Study and Review of Literature.
P300 作为向精神病转变和缓解的指标:来自精神病临床高风险研究和文献综述的数据。
  • DOI:
    10.1016/j.schres.2019.02.014
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    4.5
  • 作者:
    Yingying Tang;Junjie Wang;Tianhong Zhang;Lihua Xu;Zhenying Qian;Huiru Cui;Xiaochen Tang;Huijun Li;Susan Whitfield-Gabrieli;Martha E Shenton;Larry J Seidman;Robert W McCarley;Matcheri S Keshavan;William S Stone;Jijun Wang;Margaret A Niznikiewicz
  • 通讯作者:
    Margaret A Niznikiewicz

Robert W McCarley的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Robert W McCarley', 18)}}的其他基金

Basal Forebrain Cellular Mechanisms of Cortical Activation
皮质激活的基底前脑细胞机制
  • 批准号:
    8242210
  • 财政年份:
    2011
  • 资助金额:
    $ 31.21万
  • 项目类别:
Basal Forebrain Cellular Mechanisms of Cortical Activation
皮质激活的基底前脑细胞机制
  • 批准号:
    8413399
  • 财政年份:
    2011
  • 资助金额:
    $ 31.21万
  • 项目类别:
Basal Forebrain Cellular Mechanisms of Cortical Activation
皮质激活的基底前脑细胞机制
  • 批准号:
    8598052
  • 财政年份:
    2011
  • 资助金额:
    $ 31.21万
  • 项目类别:
PROJECT 3: ELECTROPHYSIOLOGICAL & GRAY MATTER MARKERS & PREDICTORS OF PROGRESSION
项目 3:电生理学
  • 批准号:
    8136028
  • 财政年份:
    2010
  • 资助金额:
    $ 31.21万
  • 项目类别:
CORE 1: OPERATIONS AND CLINICAL ASSESSMENT
核心 1:操作和临床评估
  • 批准号:
    8136030
  • 财政年份:
    2010
  • 资助金额:
    $ 31.21万
  • 项目类别:
Project 3 HMS - VA sub
项目 3 HMS - VA 子
  • 批准号:
    8794523
  • 财政年份:
    2010
  • 资助金额:
    $ 31.21万
  • 项目类别:
MRI Anatomy of Schizophrenia
精神分裂症的 MRI 解剖
  • 批准号:
    8586849
  • 财政年份:
    2009
  • 资助金额:
    $ 31.21万
  • 项目类别:
MRI Anatomy of Schizophrenia
精神分裂症的 MRI 解剖
  • 批准号:
    7906935
  • 财政年份:
    2009
  • 资助金额:
    $ 31.21万
  • 项目类别:
Vulnerability to Progression Schizophrenia
精神分裂症进展的脆弱性
  • 批准号:
    7929313
  • 财政年份:
    2009
  • 资助金额:
    $ 31.21万
  • 项目类别:
MRI Anatomy of Schizophrenia
精神分裂症的 MRI 解剖
  • 批准号:
    8195955
  • 财政年份:
    2009
  • 资助金额:
    $ 31.21万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 31.21万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.21万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 31.21万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.21万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 31.21万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.21万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 31.21万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 31.21万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 31.21万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.21万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了